Skip to main content

MoneyWorks4Me

Earum Pharmaceuticals informs about disclosure

07 Jul 2023 Evaluate

Earum Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nimit Jayendrabhai Shah.

The above information is a part of company’s filings submitted to BSE.

Peers